| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.2741/3872 |
| P698 | PubMed publication ID | 21622195 |
| P2093 | author name string | Suresh K Alahari | |
| Allison Berrier | |||
| Rajamani Rathinam | |||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2561-2571 | |
| P577 | publication date | 2011-06-01 | |
| P1433 | published in | Frontiers in Bioscience | Q5506062 |
| P1476 | title | Role of Rho GTPases and their regulators in cancer progression | |
| P478 | volume | 16 |
| Q39261026 | A non-secretory form of FAM3B promotes invasion and metastasis of human colon cancer cells by upregulating Slug expression |
| Q85855984 | Advances in the pharmacological activities and mechanisms of diosgenin |
| Q37175141 | ArhGAP15, a Rac-specific GTPase-activating protein, plays a dual role in inhibiting small GTPase signaling |
| Q52958332 | CDC42 Gtpase Activation Affects Hela Cell DNA Repair and Proliferation Following UV Radiation-Induced Genotoxic Stress. |
| Q28594921 | CDC42 is required for structural patterning of the lung during development |
| Q34656836 | CDK5 is a major regulator of the tumor suppressor DLC1 |
| Q55039402 | CHL1 gene acts as a tumor suppressor in human neuroblastoma. |
| Q36708621 | Characterization of a Cdc42 protein inhibitor and its use as a molecular probe |
| Q34736407 | Cidofovir selectivity is based on the different response of normal and cancer cells to DNA damage |
| Q94465733 | Computational and in vitro Pharmacodynamics Characterization of 1A-116 Rac1 Inhibitor: Relevance of Trp56 in Its Biological Activity |
| Q36557347 | Deoxypodophyllotoxin suppresses tumor vasculature in HUVECs by promoting cytoskeleton remodeling through LKB1-AMPK dependent Rho A activatio |
| Q38230630 | Development of EHop-016: a small molecule inhibitor of Rac. |
| Q38728565 | Developmental pathways associated with cancer metastasis: Notch, Wnt, and Hedgehog |
| Q92603932 | Diallyl disulfide inhibits colon cancer metastasis by suppressing Rac1-mediated epithelial-mesenchymal transition |
| Q50913500 | Effect of Rac1 downregulation mediated by shRNA on the biological behaviour of human cervical cancer cells. |
| Q92596472 | Effect of the Large and Small T-Antigens of Human Polyomaviruses on Signaling Pathways |
| Q49996639 | Endothelial Cdc42 deficiency impairs endothelial regeneration and vascular repair after inflammatory vascular injury. |
| Q38452303 | Enteropathogenic Escherichia coli-induced macrophage inhibitory cytokine 1 mediates cancer cell survival: an in vitro implication of infection-linked tumor dissemination |
| Q34130368 | Expression and significance of Rac1, Pak1 and Rock1 in gastric carcinoma |
| Q57492895 | F806 Suppresses the Invasion and Metastasis of Esophageal Squamous Cell Carcinoma via Downregulating F-Actin Assembly-Related Rho Family Proteins |
| Q38114125 | FilGAP and its close relatives: a mediator of Rho-Rac antagonism that regulates cell morphology and migration |
| Q30426476 | GEP100/Arf6 is required for epidermal growth factor-induced ERK/Rac1 signaling and cell migration in human hepatoma HepG2 cells |
| Q35034732 | Ganoderiol A-enriched extract suppresses migration and adhesion of MDA-MB-231 cells by inhibiting FAK-SRC-paxillin cascade pathway |
| Q39257808 | Geranylgeranyltransferase I promotes human glioma cell growth through Rac1 membrane association and activation |
| Q39182934 | Geranylgeranyltransferase I regulates HIF-1α promoting glioblastoma cell migration and invasion |
| Q99552874 | IL-37: An anti-inflammatory cytokine with antitumor functions |
| Q27684047 | In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12C |
| Q36864327 | Increased hippocampal NgR1 signaling machinery in aged rats with deficits of spatial cognition. |
| Q38932403 | Inhibition of invasion and metastasis of human liver cancer HCCLM3 cells by portulacerebroside A. |
| Q47652910 | Intracellular mature IL-37 suppresses tumor metastasis via inhibiting Rac1 activation |
| Q39347740 | KRas induces a Src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancreatic cancer |
| Q37706000 | LMO2 promotes tumor cell invasion and metastasis in basal-type breast cancer by altering actin cytoskeleton remodeling |
| Q38106675 | Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors. |
| Q39207731 | Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1. |
| Q37699390 | Negative feedback between TAp63 and Mir-133b mediates colorectal cancer suppression |
| Q34559550 | Nischarin is differentially expressed in rat brain and regulates neuronal migration |
| Q42125679 | Optimization and stabilization of Rho small GTPase proteins for solution NMR studies: The case of Rnd1. |
| Q38993815 | PIKfyve, MTMR3 and their product PtdIns5P regulate cancer cell migration and invasion through activation of Rac1. |
| Q38145091 | RAC1: an emerging therapeutic option for targeting cancer angiogenesis and metastasis |
| Q38095807 | RNA interference in the treatment of colon cancer |
| Q36905661 | Rab23 promotes squamous cell carcinoma cell migration and invasion via integrin β1/Rac1 pathway |
| Q90471584 | Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer |
| Q53644979 | Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome. |
| Q39718274 | Rac1 is a potential target to circumvent radioresistance |
| Q37427965 | Rac1 overexpression is correlated with epithelial mesenchymal transition and predicts poor prognosis in non-small cell lung cancer |
| Q34021751 | Regulation of EMT by KLF4 in gastrointestinal cancer |
| Q43293077 | Relationship of light scatter change and Cdc42-regulated actin status. |
| Q27003967 | Rho GTPases and their roles in cancer metabolism |
| Q42642979 | Rho GTPases central regulators of cell migration |
| Q38050708 | Rho GTPases in animal cell cytokinesis: an occupation by the one percent |
| Q39085721 | RhoA and RhoC differentially modulate estrogen receptor α recruitment, transcriptional activities, and expression in breast cancer cells (MCF-7). |
| Q30301104 | RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer. |
| Q35665403 | RhoC and ROCKs regulate cancer cell interactions with endothelial cells. |
| Q21134105 | RhoT1 and Smad4 are correlated with lymph node metastasis and overall survival in pancreatic cancer |
| Q38264091 | Role of MTA1 in head and neck cancers |
| Q53320449 | Role of Rac1 Pathway in Epithelial-to-Mesenchymal Transition and Cancer Stem-like Cell Phenotypes in Gastric Adenocarcinoma. |
| Q38295763 | Sialylation and glycosylation modulate cell adhesion and invasion to extracellular matrix in human malignant lymphoma: Dependency on integrin and the Rho GTPase family |
| Q34994130 | Silencing of CDC42 inhibits neuroblastoma cell proliferation and transformation |
| Q36015790 | Silencing of Rac1 expression via RNA interference inhibits retinal neovascularization in rats. |
| Q41871186 | Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling |
| Q36988768 | Statins and colorectal cancer |
| Q36304158 | TOR under stress: targeting TORC1 by Rho1 GTPase |
| Q37107309 | TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance. |
| Q27675453 | Ternary complex structures of human farnesyl pyrophosphate synthase bound with a novel inhibitor and secondary ligands provide insights into the molecular details of the enzyme’s active site closure |
| Q37387817 | The Rac-GAP Bcr is a novel regulator of the Par complex that controls cell polarity. |
| Q41036627 | The Structural Basis for Cdc42-Induced Dimerization of IQGAPs |
| Q24297013 | The catalytic phosphoinositol 3-kinase isoform p110δ is required for glioma cell migration and invasion |
| Q38924969 | The interaction of Wnt-11 and signalling cascades in prostate cancer |
| Q26766212 | The involvement of mutant Rac1 in the formation of invadopodia in cultured melanoma cells |
| Q35742306 | The mevalonate pathway in C. elegans |
| Q26768676 | The role of pluripotency factors to drive stemness in gastrointestinal cancer |
| Q88965519 | Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers |
| Q47564438 | Unraveling the molecular mechanism of interactions of the Rho GTPases Cdc42 and Rac1 with the scaffolding protein IQGAP2. |
| Q55711392 | miR-124-3p acts as a potential marker and suppresses tumor growth in gastric cancer. |
| Q49500445 | shRNA-induced silencing of Ras-related C3 botulinum toxin substrate 1 inhibits the proliferation of colon cancer cells through upregulation of BAD and downregulation of cyclin D1. |
Search more.